Organon Days Sales in Receivables 2019-2024 | OGN
Current and historical days sales in receivables for Organon (OGN) from 2019 to 2024. Days sales in receivables can be defined as the average number of days it takes to collect outstanding receiveable amounts from customers. Organon days sales in receivables for the three months ending March 31, 2024 was 85.84.
| Organon Days Sales in Receivables Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.385B | $6.263B |
| Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $117.915B | 14.80 |
| Cencora (COR) | United States | $43.985B | 17.15 |
| ICON (ICLR) | Ireland | $26.639B | 25.15 |
| DiDi Global (DIDIY) | China | $22.358B | 0.00 |
| Avantor (AVTR) | United States | $16.031B | 23.60 |
| CochLear (CHEOY) | Australia | $13.625B | 0.00 |
| Natera (NTRA) | United States | $13.523B | 0.00 |
| Revvity (RVTY) | United States | $13.368B | 23.45 |
| Viatris (VTRS) | United States | $12.478B | 3.73 |
| Medpace Holdings (MEDP) | United States | $11.950B | 39.32 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.358B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.803B | 20.68 |
| Solventum (SOLV) | United States | $10.078B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.710B | 0.00 |
| HealthEquity (HQY) | United States | $6.884B | 50.72 |
| Bausch + Lomb (BLCO) | Canada | $5.410B | 21.68 |
| Doximity (DOCS) | United States | $5.177B | 36.04 |
| PACS (PACS) | United States | $4.499B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.467B | 31.72 |
| Life Times (LTH) | United States | $3.279B | 34.35 |
| Sotera Health (SHC) | United States | $3.139B | 15.40 |
| GoodRx Holdings (GDRX) | United States | $2.837B | 108.00 |
| Agilon Health (AGL) | United States | $2.566B | 0.00 |
| Progyny (PGNY) | United States | $2.535B | 43.64 |
| NovoCure (NVCR) | Jersey | $2.397B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.064B | 8.18 |
| Premier (PINC) | United States | $1.985B | 8.49 |
| BrightSpring Health Services (BTSG) | United States | $1.962B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.915B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.507B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.420B | 0.00 | |
| Embecta (EMBC) | United States | $0.717B | 4.87 |
| CareDx (CDNA) | United States | $0.704B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.645B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.619B | 6.57 |
| InnovAge Holding (INNV) | United States | $0.589B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| GeneDx Holdings (WGS) | United States | $0.533B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.507B | 0.00 |
| Enhabit (EHAB) | United States | $0.461B | 46.00 |
| ModivCare (MODV) | United States | $0.403B | 7.54 |
| Sonida Senior Living (SNDA) | United States | $0.383B | 0.00 |
| LifeMD (LFMD) | United States | $0.359B | 0.00 |
| MultiPlan (MPLN) | United States | $0.348B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.324B | 0.00 |
| Sharecare (SHCR) | United States | $0.306B | 0.00 |
| DocGo (DCGO) | United States | $0.300B | 16.39 |
| Beauty Health (SKIN) | United States | $0.270B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.223B | 0.00 |
| Biodesix (BDSX) | United States | $0.155B | 0.00 |
| So-Young (SY) | China | $0.104B | 52.50 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.71 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Oncology Institute (TOI) | United States | $0.035B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| DermTech (DMTK) | United States | $0.011B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| OpGen (OPGN) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |